Maryland Capital Management Purchases 2,300 Shares of Merck & Co.
Maryland Capital Management increased its stake in shares of Merck & Co. by 5.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission .
from Biotech News
0 Comments